Cigna Express Scripts News Today

Trish Jackson is currently a marketing campaign analyst for Cigna-Express Scripts.

Congress and the administration still have time (NOT MUCH) to act...

Alexandria, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- As rumors swirl in Washington, D.C., that lawmakers may once again be punting on PBM reform, the National Community Pharmacists Association today

NCPA is skeptical that Express Scripts, owned by Cigna, will walk the walk on its recent announcement that it plans to evolve the one-sided business relationship PBMs exploit that results in decreased transparency, higher patient prescription drug costs, and stifled competition. Based on past actions by Cigna-Express Scripts, NCPA believes there is no basis for independent pharmacies to have confidence they will actually see increased reimbursements from Cigna-Express Scripts.

Plus: Taconic Partners' Upper East Side lab totaling $350M to open in 2025 Mount Sinai gets $60M to build Tisch Cancer Hospital Community Healthcare Network secures 35-year lease for Bronx FQHC

It's a question echoed throughout every corner of the United States: Why are prescription drug prices so high? ...

The largest six pharmacy benefit managers are being scrutinized by the Federal Trade Commission, while Congress is debating the Pharmacy Benefit Transparency Act. Meanwhile, states have their own ideas for reining in what they see as excesses of the industry. With all this heat, what is the message from the head of the Pharmaceutical Care Management Association?

Dear Colleague, The stock market has been pounded this week but over the last five years, the S&P 500 is still up about 60 percent and the NASDAQ, about 83 percent. Now, I’m far from being an investor pro. For example, I bought $2,000 of Warner-Lambert stock as a 26-year-old, only to sell it a few months later for $2,500 thinking I had struck it rich with my $500 profit. Don’t even ask me about the opportunity for Chipotle shares when it split from McDonald’s in 2006. Experience and hi...

The end of 2021 marks the deadline for former Express Scripts CEO Tim Wentworth's stock and equity awards to vest.